You've just added:

Home / News

News + Media

August 18, 2021

New Study Finds Therapeutic Treatment Option for Metabolic Syndrome, Obesity

CLEVELAND—Metabolic syndrome is a cluster of conditions and includes obesity, and can be dangerous as it increases the risk for heart disease, stroke, diabetes and other diseases. In a recent study, published in , researchers at Harrington Discovery Institute at University Hospitals (UH) have discovered a therapeutic option... Continue Reading

August 02, 2021

Nominations Open for 9th Annual Harrington Prize for Innovation in Medicine

CLEVELAND, Ohio – National and international nominations are being sought for the 2022 Harrington Prize for Innovation in Medicine, which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential for clinical application.The Harrington Prize, which... Continue Reading

July 13, 2021

Harrington Discovery Institute Announces 2021 Scholar-Innovator Award Recipients

CLEVELAND, Ohio – The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2021 class of Harrington Scholar-Innovators. The scholar awards will support a diverse set of drug discovery projects including new treatments for multiple cancers, cardiovascular disease, Graft vs. Host... Continue Reading

July 01, 2021

The Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute to Support Promising Research to Restore Brain Function in People with Alzheimer’s Disease

NEW YORK, NY – The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals in Cleveland have granted to two Principal Investigators, Paul Fish, Ph.D., of University College London’s Drug Discovery Institute and Paul Worley, M.D., of Johns Hopkins University.Dr. Fish and Dr.... Continue Reading

May 30, 2021

Amgen to Acquire Rodeo Therapeutics Corporation

THOUSAND OAKS, Calif. and SEATTLE, March 30, 2021 /PRNewswire/ -- Amgen Inc. (NASDAQ:) and Rodeo Therapeutics Corporation (Rodeo) today announced an agreement under which Amgen will acquire Rodeo, a privately held biopharmaceutical company based in Seattle that develops small-molecule therapies designed to promote regeneration... Continue Reading

March 29, 2021

The Harrington Discovery Institute Supports COVID-19 Antibody Therapy Development at the Rockefeller University

NEW YORK, NY, March 29, 2021—The Rockefeller University has received supplemental grant support from the Harrington Discovery Institute to help fund the testing of a monoclonal antibody drug for the prevention and early treatment of COVID-19. The drug is the result of a collaborative research effort launched in the first... Continue Reading

March 24, 2021

International Harrington Prize Jointly Awarded to Dr. Warren Leonard and John O'Shea

Cleveland, Ohio – The eighth annual Harrington Prize for Innovation in Medicine has been jointly awarded to Warren J. Leonard, MD, NHLBI, NIH Distinguished Investigator, and John J. O’Shea, MD, Scientific Director, NIAMS, NIH, for their respective contributions to the field of immunology, from fundamental discovery to... Continue Reading

March 15, 2021

Harrington Discovery Institute at University Hospitals Opens Call for 2022 Harrington Scholar-Innovator Award

CLEVELAND, Ohio USA – The 2022 Harrington Scholar-Innovator Award is now open and accepting Letters of Intent. The award offers inventive physician-scientists resources and expertise to advance their discoveries into medicines. Intellectual property rights are retained by the award recipient or his or her institution. Up to... Continue Reading

March 02, 2021

Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute Invite Proposals for 2021 ADDF-Harrington Scholar Award

Cleveland, Ohio – Harrington Discovery Institute at University Hospitals and the Alzheimer's Drug Discovery Foundation (ADDF) announce a joint request for proposals for the . The ADDF-Harrington Scholar Award is designed to accelerate the translation of innovative research that could treat, prevent, or slow Alzheimer's... Continue Reading

February 18, 2021

Harrington Discovery Institute Announces New Fund to Advance Breakthrough Discoveries into Novel Treatments

CLEVELAND, OH—The transatlantic, not-for-profit medical accelerator, Harrington Discovery Institute at University Hospitals, has collaborated with leading venture investor, Advent Life Sciences (‘Advent’) in the launch of the Advent-Harrington Impact Fund.Advent’s new impact fund, structured alongside Advent Life... Continue Reading